Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C

por Flores-Contreras, Lucia, Sandoval-Rodríguez, Ana S, Mena-Enriquez, Mayra G, Lucano-Landeros, Silvia, Arellano-Olivera, Inmaculada, Álvarez-Álvarez, Arnulfo, Sanchez-Parada, M Guadalupe, Armendáriz-Borunda, Juan
Publicado 2014